A new peer-reviewed analysis suggests the current regulatory framework is performing exactly as designed, keeping federal health agencies completely isolated from distressing reports of infant fatalities.
According to a paper published Thursday in JAMA Pediatrics, the long-standing protocol of allowing infant formula companies to decide whether their own products are killing babies has yielded remarkably consistent results. Researchers analyzing the regulatory pipeline found a strong inverse association between the number of grieving parents calling consumer hotlines and the amount of data subsequently forwarded to the Food and Drug Administration. However, authors of the paper were quick to note that correlation does not equal causation, and that a lack of federal oversight cannot definitively be proven to cause the lack of federal oversight.
Under current FDA guidelines, when manufacturers like Abbott Nutrition or Reckitt Benckiser receive reports of severe bacterial infections or deaths linked to products like Similac or Enfamil, the companies initiate a rigorous internal screening process. This self-guided methodology empowers the corporation to carefully evaluate the maternal reports, weigh the potential market impacts, and ultimately conclude that the federal government probably has enough on its plate right now. Experts caution against jumping to conclusions about the safety of the food supply simply because the companies producing it are the sole arbiters of what constitutes a fatal adverse event.
While the sudden loss of a newborn is always a deeply unfortunate data point, we must be careful not to conflate a mother’s unverified phone call with a rigorous clinical trial.
The study's authors emphasized that more research is needed before regulators consider altering the current honor system. While some consumer advocates have hypothesized that mandatory reporting might provide a clearer clinical picture of how many newborns are contracting Cronobacter sakazakii from powdered formula, medical ethicists warn that forcing corporations to disclose their own lethal contamination incidents could introduce severe compliance biases. In the interim, the FDA recommends that parents who suspect their child’s formula may be fatal continue to direct their inquiries to the manufacturer's automated customer service portal, where the data can be safely contained.